Challenges in oncology. Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571

J Clin Oncol. 2002 Feb 1;20(3):869-70. doi: 10.1200/JCO.2002.20.3.869.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Humans
  • Hypopigmentation / chemically induced*
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Male
  • Middle Aged
  • Piperazines / adverse effects*
  • Pyrimidines / adverse effects*

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate